Vascular endothelial growth factor and social support in patients with ovarian carcinoma - PubMed (original) (raw)
. 2002 Aug 15;95(4):808-15.
doi: 10.1002/cncr.10739.
Affiliations
- PMID: 12209725
- DOI: 10.1002/cncr.10739
Free article
Vascular endothelial growth factor and social support in patients with ovarian carcinoma
Susan K Lutgendorf et al. Cancer. 2002.
Free article
Abstract
Background: The modulation of immunologic activities relevant to cancer by behavioral factors, such as stress, depression, and social support, is well documented. However, associations of behavioral factors with cytokines involved in tumor angiogenesis have not been studied. Vascular endothelial growth factor (VEGF) is a key cytokine that is capable of stimulating tumor angiogenesis, and it has been associated with poorer survival in patients with ovarian carcinoma. VEGF is modulated by a variety of behaviorally sensitive factors, including sympathetic activation. This study examined relationships of social support and depressive symptoms with VEGF levels in preoperative patients with ovarian carcinoma.
Methods: Twenty-four women with ovarian carcinoma and 5 women with benign pelvic masses were recruited at the presurgical clinic visit, received psychosocial surveys, including the Functional Assessment of Cancer Therapy (Quality of Life) survey and the Profile of Mood States, and a blood draw. Serum VEGF levels were assessed by enzyme-linked immunosorbent assay. Analyses controlled for disease stage.
Results: Women with ovarian carcinoma who reported higher levels of social well being had lower levels of VEGF (P = 0.005). Greater support from friends and neighbors (P = 0.005) and less distance from friends (P = 0.04) were facets of social well being that were associated with lower VEGF levels. Individuals who reported greater helplessness (P = 0.03) or worthlessness (P = 0.08) had higher VEGF levels, but depression as a whole (P > 0.50) was not related to VEGF levels.
Conclusions: Higher levels of social well being were correlated with lower VEGF levels in presurgical patients with ovarian carcinoma. These findings suggest a possible mechanism by which poor social support may be associated with disease progression. Further study of these relations may demonstrate novel pathways relating biobehavioral factors to tumor growth and disease progression.
Copyright 2002 American Cancer Society.DOI 10.1002/cncr.10739
Similar articles
- Vascular endothelial growth factor in the sera and effusions of patients with malignant and nonmalignant disease.
Kraft A, Weindel K, Ochs A, Marth C, Zmija J, Schumacher P, Unger C, Marmé D, Gastl G. Kraft A, et al. Cancer. 1999 Jan 1;85(1):178-87. Cancer. 1999. PMID: 9921991 - Serum vascular endothelial growth factor in epithelial ovarian neoplasms: correlation with patient survival.
Chen CA, Cheng WF, Lee CN, Chen TM, Kung CC, Hsieh FJ, Hsieh CY. Chen CA, et al. Gynecol Oncol. 1999 Aug;74(2):235-40. doi: 10.1006/gyno.1999.5418. Gynecol Oncol. 1999. PMID: 10419737 - Vascular endothelial growth factor activating matrix metalloproteinase in ascitic fluid during peritoneal dissemination of ovarian cancer.
Yabushita H, Shimazu M, Noguchi M, Kishida T, Narumiya H, Sawaguchi K, Noguchi M. Yabushita H, et al. Oncol Rep. 2003 Jan-Feb;10(1):89-95. Oncol Rep. 2003. PMID: 12469150 - [Growth factors in epithelial ovarian cancer].
Piccinno R, Puopolo M, Rigault De La Longrais IA, Fracchioli S, Massobrio M, Katsaros D. Piccinno R, et al. Minerva Ginecol. 2002 Feb;54(1):33-52. Minerva Ginecol. 2002. PMID: 11828269 Review. Italian. - [Bronchogenic carcinoma and antiangiogenic therapy].
Qi X, Rao W. Qi X, et al. Zhonghua Jie He He Hu Xi Za Zhi. 2000 Aug;23(8):492-4. Zhonghua Jie He He Hu Xi Za Zhi. 2000. PMID: 11778266 Review. Chinese. No abstract available.
Cited by
- Living Well: Protocol for a web-based program to improve quality of life in rural and urban ovarian cancer survivors.
Pennington KP, Schlumbrecht M, McGregor BA, Goodheart MJ, Heron L, Zimmerman B, Telles R, Zia S, Penedo FJ, Lutgendorf SK. Pennington KP, et al. Contemp Clin Trials. 2024 Sep;144:107612. doi: 10.1016/j.cct.2024.107612. Epub 2024 Jun 22. Contemp Clin Trials. 2024. PMID: 38914309 - Environmental signals perceived by the brain abate pro-metastatic monocytes by dampening glucocorticoids receptor signaling.
Canali MM, Guyot M, Simon T, Daoudlarian D, Chabry J, Panzolini C, Petit-Paitel A, Hypolite N, Nicolas S, Bourdely P, Schmid-Antomarchi H, Schmid-Alliana A, Soria J, Karimdjee Soilihi B, Hofman P, Prevost-Blondel A, Kato M, Mougneau E, Glaichenhaus N, Blancou P. Canali MM, et al. Cancer Cell Int. 2023 Feb 1;23(1):15. doi: 10.1186/s12935-023-02855-4. Cancer Cell Int. 2023. PMID: 36726173 Free PMC article. - Pre-Surgery Inflammatory and Angiogenesis Biomarkers as Predictors of 12-Month Cancer-Related Distress: Results from the ColoCare Study.
Lindley CL, Gigic B, Peoples AR, Han CJ, Lin T, Himbert C, Warby CA, Boehm J, Hardikar S, Ashworth A, Schneider M, Ulrich A, Schrotz-King P, Figueiredo JC, Li CI, Shibata D, Siegel EM, Toriola AT, Ulrich CM, Syrjala KL, Ose J. Lindley CL, et al. Cancer Epidemiol Biomarkers Prev. 2023 Mar 6;32(3):363-370. doi: 10.1158/1055-9965.EPI-22-0882. Cancer Epidemiol Biomarkers Prev. 2023. PMID: 36595657 Free PMC article. - Effect of chronic stress on tumorigenesis and development.
Wang C, Shen Y, Ni J, Hu W, Yang Y. Wang C, et al. Cell Mol Life Sci. 2022 Aug 16;79(9):485. doi: 10.1007/s00018-022-04455-3. Cell Mol Life Sci. 2022. PMID: 35974132 Free PMC article. Review. - Biobehavioral Pathways and Cancer Progression: Insights for Improving Well-Being and Cancer Outcomes.
Chang A, Sloan EK, Antoni MH, Knight JM, Telles R, Lutgendorf SK. Chang A, et al. Integr Cancer Ther. 2022 Jan-Dec;21:15347354221096081. doi: 10.1177/15347354221096081. Integr Cancer Ther. 2022. PMID: 35579197 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Molecular Biology Databases